{"id":258136,"date":"2026-09-21T09:51:00","date_gmt":"2026-09-21T04:21:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=258136"},"modified":"2026-09-21T09:51:00","modified_gmt":"2026-09-21T04:21:00","slug":"why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/","title":{"rendered":"Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price rises 2.23% today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\">Caplin Point Laboratories Ltd. (CAPLIPOINT)<\/a> share price rose to Rs 2,809.25 today, up 2.23% from the previous close. Market cap was Rs 20,886.87 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 21 September 2026 at 9:19:50 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Caplin Point Laboratories Share Price rose to Rs 2,809.25 today, up 2.23% from the previous close of Rs 2,747.85, while the company\u2019s market capitalisation stood at Rs 20,886.87 Cr. The move places Caplin Point Laboratories Ltd. in today\u2019s stock news flow as a notable share price rise in the healthcare space. Based on the supplied data, the article confirms the price event and the day\u2019s trading range, but it does not establish a company-specific catalyst. For readers tracking Caplin Point Laboratories Share Price Today, the useful context is the size of the move, the turnover of Rs 0.17 Cr, and how the stock compares with sector valuation and peer metrics. Univest will continue to track the stock through its market data and analysis framework.<\/p>\n<p>Caplin Point Laboratories Share Price also matters because the company is already valued at a premium to the wider industry medians on some metrics, while still sitting inside a sector that includes much larger listed names. That combination makes Caplin Point Laboratories Stock News relevant for investors who watch price action alongside fundamentals, sector positioning and ownership structure.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Caplin_Point_Laboratories_Share_Price_Today_Price_Action_Analysis\" title=\"Caplin Point Laboratories Share Price Today: Price Action Analysis\">Caplin Point Laboratories Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Caplin_Point_Laboratories_Ltd_CAPLIPOINT_Fundamental_Analysis\" title=\"Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis\">Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Why_Investors_Are_Watching_Caplin_Point_Laboratories\" title=\"Why Investors Are Watching Caplin Point Laboratories\">Why Investors Are Watching Caplin Point Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#About_Caplin_Point_Laboratories_Ltd\" title=\"About Caplin Point Laboratories Ltd.\">About Caplin Point Laboratories Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Track_Caplin_Point_Laboratories_Share_Price_on_Univest\" title=\"Track Caplin Point Laboratories Share Price on Univest\">Track Caplin Point Laboratories Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Why_is_Caplin_Point_Laboratories_Share_Price_rising_today\" title=\"Why is Caplin Point Laboratories Share Price rising today?\">Why is Caplin Point Laboratories Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#What_is_Caplin_Point_Laboratories_Share_Price_today\" title=\"What is Caplin Point Laboratories Share Price today?\">What is Caplin Point Laboratories Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#What_is_Caplin_Point_Laboratories_market_capitalisation\" title=\"What is Caplin Point Laboratories market capitalisation?\">What is Caplin Point Laboratories market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#How_does_Caplin_Point_Laboratories_compare_on_valuation\" title=\"How does Caplin Point Laboratories compare on valuation?\">How does Caplin Point Laboratories compare on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#What_do_Caplin_Point_Laboratories_ROE_and_ROCE_show\" title=\"What do Caplin Point Laboratories ROE and ROCE show?\">What do Caplin Point Laboratories ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#What_are_the_EPS_and_book_value_for_Caplin_Point_Laboratories\" title=\"What are the EPS and book value for Caplin Point Laboratories?\">What are the EPS and book value for Caplin Point Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-price-rise-2026-09-21\/#Does_Caplin_Point_Laboratories_pay_a_dividend\" title=\"Does Caplin Point Laboratories pay a dividend?\">Does Caplin Point Laboratories pay a dividend?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Caplin Point Laboratories Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,809.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,747.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 61.4 (+2.23%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,760<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,815.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,710<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.17 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20,886.87 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) rose to Rs 2,809.25 from the previous close of Rs 2,747.85, a move of Rs 61.4 or 2.23%. The stock opened at Rs 2,760, reached a high of Rs 2,815.95, recorded a low of Rs 2,710.<\/p>\n<p>Caplin Point Laboratories Share Price today opened at Rs 2,760, touched a high of Rs 2,815.95 and a low of Rs 2,710, before settling at Rs 2,809.25. The stock gained Rs 61.40 over the previous close of Rs 2,747.85, and the supplied data confirms a same-day price rise. The turnover for the session was Rs 0.17 Cr. No company-specific catalyst is confirmed in the supplied data, so the event should be read as a verified price move rather than a reason-based story. For Caplin Point Laboratories Share Price Today searches, these figures capture the day\u2019s movement, range and closing level.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_Ltd_CAPLIPOINT_Fundamental_Analysis\"><\/span><strong>Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20,886.87 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.97%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 87.53<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 483.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.29%<\/td>\n<\/tr>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P\/E 31.39x, P\/B 5.69x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Caplin Point Laboratories Ltd. has a market capitalisation of Rs 20886.87 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 31.39x, P\/B at 5.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.29%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.4x to 683.5x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.08x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.97%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.46%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20,886.87 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 701.78 crore<\/td>\n<\/tr>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P\/E ratio of 31.39x, which is below the benchmark median of 32.87x, a difference of -4.5%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.7%, a difference of +77.69%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.46%, a difference of +85.51%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,40,397.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,48,664.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,82,738.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,012.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,793.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P\/E ratio of 31.39x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.79% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 20,886.87 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Caplin_Point_Laboratories\"><\/span><strong>Why Investors Are Watching Caplin Point Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Caplin Point Laboratories Share Price rose 2.23% today to Rs 2,809.25.<\/li>\n<li>The stock moved Rs 61.40 above the previous close of Rs 2,747.85.<\/li>\n<li>Market capitalisation stands at Rs 20,886.87 Cr for Caplin Point Laboratories Share Price.<\/li>\n<li>P\/E is 31.39, P\/B is 5.69, EPS is Rs 87.53 and book value is Rs 483.17.<\/li>\n<li>ROE of 20.79% and ROCE of 24.97% compare favourably with the industry medians.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Caplin_Point_Laboratories_Ltd\"><\/span><strong>About Caplin Point Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Caplin Point Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied data does not break out product segments or revenue mix, so the company is best understood here through its listed financial and market profile. Caplin Point Laboratories Share Price is being tracked because the company combines a sizeable market capitalisation with strong return ratios and a valuation that can be compared against a broad same-industry benchmark. Its earnings per share of Rs 87.53 and book value of Rs 483.17 provide a useful snapshot of underlying financial scale, while the dividend yield of 0.29% shows a modest payout profile. For readers following Caplin Point Laboratories Stock News, the main company-level takeaway is that the business sits inside a competitive pharmaceutical universe where valuation, profitability and relative market size all matter.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Caplin_Point_Laboratories_Share_Price_on_Univest\"><\/span><strong>Track Caplin Point Laboratories Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\">Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>You can track Caplin Point Laboratories Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Caplin Point Laboratories Share Price Today alongside company news, sector context and peer comparison in one place. For Caplin Point Laboratories Stock Analysis, that combination makes it easier to review the numbers that matter without separating the stock story from the wider market backdrop.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Caplin_Point_Laboratories_Share_Price_rising_today\"><\/span><strong>Why is Caplin Point Laboratories Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms a same-day price rise of 2.23% to Rs 2,809.25. It does not establish a company-specific catalyst, so the event should be read as a verified market move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Caplin_Point_Laboratories_Share_Price_today\"><\/span><strong>What is Caplin Point Laboratories Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories Share Price today is Rs 2,809.25. It moved up Rs 61.40 from the previous close of Rs 2,747.85, with the day\u2019s high at Rs 2,815.95. The previous close was Rs 2,747.85.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Caplin_Point_Laboratories_market_capitalisation\"><\/span><strong>What is Caplin Point Laboratories market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories has a market capitalisation of Rs 20,886.87 Cr. That places the company above the industry median in the supplied benchmark set, while still below the largest healthcare peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Caplin_Point_Laboratories_compare_on_valuation\"><\/span><strong>How does Caplin Point Laboratories compare on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a P\/E of 31.39 and a P\/B of 5.69. Its P\/E is below the industry median, while its P\/B is above the median and average in the benchmark universe.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Caplin_Point_Laboratories_ROE_and_ROCE_show\"><\/span><strong>What do Caplin Point Laboratories ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories reports ROE of 20.79% and ROCE of 24.97%. Both are above the industry median and average in the supplied same-industry benchmark, which adds profitability context. ROE stands at 20.79%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_EPS_and_book_value_for_Caplin_Point_Laboratories\"><\/span><strong>What are the EPS and book value for Caplin Point Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS is Rs 87.53 and book value is Rs 483.17. EPS shows earnings attributable to each share, while book value per share shows the accounting net worth behind each share.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Caplin_Point_Laboratories_pay_a_dividend\"><\/span><strong>Does Caplin Point Laboratories pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied dividend yield is 0.29%. That is historical payout data linked to the current price, so it provides context for income-oriented analysis rather than a guarantee of future payouts.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Caplin Point Laboratories Ltd. Share Price rises to Rs 2,809.25. marking a 2.23% rise today. Market cap stands at Rs 20,886.87 crore.<\/p>\n","protected":false},"author":29,"featured_media":258132,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-258136","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["258132"],"rank_math_title":["Caplin Point Laboratories Share Price rises 2.23% today"],"rank_math_description":["Caplin Point Laboratories Share Price rose 2.23% to Rs 2,809.25. Read the price action, valuation, sector benchmark and peer comparison."],"rank_math_focus_keyword":["Caplin Point Laboratories Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Caplin_Point_Laboratories_Ltd_CAPLIPOINT_Caplin_Point_Laboratories_Share_Price_rises_223_today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/258136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=258136"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/258136\/revisions"}],"predecessor-version":[{"id":258137,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/258136\/revisions\/258137"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/258132"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=258136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=258136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=258136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}